Search - tctmd.com

Displaying 341 - 360 of 1897

Sort: Relevancy | Date

News Conference News TCT 2015

IN.PACT SFA: Benefits of DCB Persist at 2 Years

October 14, 2015

News Industry News

Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years

October 14, 2015

News Conference News TCT 2015

CREST-2 Triggers Spirited Debate on Merits of CAS vs. CEA

Todd Neale

October 14, 2015

Presentation TCT 2015

TCT 50: Peri-strut Low-Intensity Area Assessed by Midterm Follow-up Optical Coherence Tomography May Predict Target Lesion Revascularization After Stent Implantation

Presenter: Stephan Achenbach, Marc D. Feldman, Koji Kuroda

October 13, 2015

Presentation TCT 2015

TCT 73: Impact of Routine MicroNet-Covered Embolic Prevention Stent System Use on Contemporary Carotid Revascularization All-Comer PARADIGM Study

Presenter: Mark C. Bates, Mark H. Wholey, Piotr Musialek

October 13, 2015

Presentation TCT 2015

TCT 23: Patients, Lesion Characteristics, and Procedural Outcome Against Interventional Revascularization on Chronic Total Occlusion of Prior Coronary Artery Bypass Graft Surgery

Presenter: Eric A. Cohen, Truls Råmunddal, Masaki Tanabe

October 13, 2015

Presentation TCT 2015

TCT 22: Patent and Occluded Saphenous Vein Grafts as Retrograde Conduits for Percutaneous Revascularization of Coronary Chronic Total Occlusions: The Quebec Experience

Presenter: Eric A. Cohen, Truls Råmunddal, Rustem Dautov

October 13, 2015

Presentation TCT 2015

TCT 38: Long-term Clinical Outcome of Resting Pd/Pa Versus FFR-Guided Deferral of Revascularization

Presenter: Javier Escaned, Johan HC Reiber, Gilbert Wijntjens

October 13, 2015

Presentation TCT 2015

TCT 69: Impact of Stage 5 Chronic Kidney Disease in Patients Undergoing Percutaneous or Surgical Carotid Artery Revascularization Insights of the Healthcare Cost and Utilization Project's National Inpatient Sample

Presenter: Mark C. Bates, Mark H. Wholey, Fabio Lima

October 13, 2015

Presentation TCT 2015

RIVER-PCI: A Prospective, Double-Blind, Placebo-Controlled Randomized Trial of Ranolazine in Patients With Incomplete Revascularization After Coronary Intervention

Presenter: Sunil V. Rao, Giora Weisz

October 13, 2015

Presentation TCT 2015

TCT 18: Impact of Incomplete Revascularization After Percutaneous Coronary Intervention as Assessed by the SYNTAX Revascularization Index in Complex Coronary Artery Disease A SEEDS Substudy

Presenter: Eric A. Cohen, Truls Råmunddal, Nicolas Bettingeer

October 13, 2015

Presentation TCT 2015

RIVER-PCI: A Prospective, Double-blind, Placebo-Controlled Randomized Trial of Ranolazine in Patients With Incomplete Revascularization After Coronary Intervention

Presenter: Giora Weisz

October 13, 2015

News Conference News TCT 2015

Trial Results Often Struggle to Keep Pace With Evolving Technology

Nicole Lou

October 13, 2015

News Conference News TCT 2015

Thrombus Aspiration Fails to Reduce Microvascular Obstruction in Subacute STEMI

October 13, 2015

News Conference News TCT 2015

SORT-OUT VI: 3-Year Outcomes Similar With BES, ZES

October 13, 2015

News Conference News TCT 2015

RIVER-PCI: No Advantage to Ranolazine in Patients With Incomplete Revascularization

Yael L. Maxwell

October 13, 2015

News Industry News

Medical Therapy With Ranolazine Did Not Reduce Adverse Events In Patients With Persistent Untreated Heart Artery Blockages After Percutaneous Coronary Intervention

October 13, 2015

News Conference News TCT 2015

INNOVATION Study Suggests Safety of Deferred Stenting

October 13, 2015

News Conference News TCT 2015

FFR Guidance Remains Safe, Valuable in More Complex Disease

October 13, 2015

News Conference News TCT 2015

Discussion Highlights Merits, Limitations of Small Trials

Yael L. Maxwell

October 13, 2015

Advertisement

IN.PACT SFA: Benefits of DCB Persist at 2 Years

Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years

CREST-2 Triggers Spirited Debate on Merits of CAS vs. CEA

TCT 50: Peri-strut Low-Intensity Area Assessed by Midterm Follow-up Optical Coherence Tomography May Predict Target Lesion Revascularization After Stent Implantation

TCT 73: Impact of Routine MicroNet-Covered Embolic Prevention Stent System Use on Contemporary Carotid Revascularization All-Comer PARADIGM Study

TCT 23: Patients, Lesion Characteristics, and Procedural Outcome Against Interventional Revascularization on Chronic Total Occlusion of Prior Coronary Artery Bypass Graft Surgery

TCT 22: Patent and Occluded Saphenous Vein Grafts as Retrograde Conduits for Percutaneous Revascularization of Coronary Chronic Total Occlusions: The Quebec Experience

TCT 38: Long-term Clinical Outcome of Resting Pd/Pa Versus FFR-Guided Deferral of Revascularization

TCT 69: Impact of Stage 5 Chronic Kidney Disease in Patients Undergoing Percutaneous or Surgical Carotid Artery Revascularization Insights of the Healthcare Cost and Utilization Project's National Inpatient Sample

RIVER-PCI: A Prospective, Double-Blind, Placebo-Controlled Randomized Trial of Ranolazine in Patients With Incomplete Revascularization After Coronary Intervention

TCT 18: Impact of Incomplete Revascularization After Percutaneous Coronary Intervention as Assessed by the SYNTAX Revascularization Index in Complex Coronary Artery Disease A SEEDS Substudy

RIVER-PCI: A Prospective, Double-blind, Placebo-Controlled Randomized Trial of Ranolazine in Patients With Incomplete Revascularization After Coronary Intervention

Trial Results Often Struggle to Keep Pace With Evolving Technology

Thrombus Aspiration Fails to Reduce Microvascular Obstruction in Subacute STEMI

SORT-OUT VI: 3-Year Outcomes Similar With BES, ZES

RIVER-PCI: No Advantage to Ranolazine in Patients With Incomplete Revascularization

Medical Therapy With Ranolazine Did Not Reduce Adverse Events In Patients With Persistent Untreated Heart Artery Blockages After Percutaneous Coronary Intervention

INNOVATION Study Suggests Safety of Deferred Stenting

FFR Guidance Remains Safe, Valuable in More Complex Disease

Discussion Highlights Merits, Limitations of Small Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content